Bioelectronics Corp (BIEL)

[LostSaint]

More proof BIEL is -super- undervalued -NEWS-

BioElectronics Corporation Receives Major Orders From Italian Distributor
ActiPatch(TM) Chosen as A Safe and Effective Alternative to NSAIDs, Such As

Vioxx(R) and Celebrex(R)





Google+ Share with LinkedIn
FREDERICK, Md., May 5 /PRNewswire-FirstCall/ -- BioElectronics
Corporation (Pink Sheets: BIEL), the maker of the ActiPatch(TM), a drug
free anti-inflammatory patch, with an embedded battery operated microchip
delivering weeks of continuous pulsed therapy for a nickel an hour,
announced today it has received significant new orders from its Italian
distributor, TSS Medical, (Tecnica Scientifica Service). TSS Medical has
purchased this additional inventory to meet demand in Italy and other
European Union counties. BioElectronics is seeing demand for its product
increase significantly in Western Europe, which combined with expanding
sales in the U.S. and other countries, is likely to drive quarterly
revenues to record levels.

Andrew Whelan, President and CEO of BioElectronics Corp. comments,
"These are exciting times for all of us at BioElectronics. We expect demand
from Italy to increase over the coming months as the product is rolled out
to pharmacies across the country. We have also expanded the relationship
with our Italian partner to include distribution to additional areas in
Europe for which we have now received an initial stocking order. Many
Europeans are very interested in the drug-free nature of our products at a
time when NSAIDs, such as Vioxx(R) and Celebrex(R), have been determined to
have potentially serious cardiovascular side effects. We believe health
consumers with pain and soft tissue injuries will continue to view our
proven, state-of-the-art ActiPatch therapy as an effective alternative to
pharmaceuticals."

About BioElectronics Corporation

Bioelectronics Corporation is the maker of the ActiPatch(TM). ActiPatch
is a drug free anti-inflammatory patch with an embedded battery operated
microchip that delivers weeks of continuous pulsed therapy for less than a
dollar a day. The unique ActiPatch delivery system, using patented
technology, provides a cost-effective patient friendly method to reduce
soft tissue pain and swelling. ActiPatch is U.S. Government Food and Drug
Administration (FDA) cleared for use in reducing edema (swelling) following
blepharoplasty and has no known side effects. The product is also approved
by Health Canada for the relief of pain in musculoskeletal complaints and
is widely available in pharmacies across Canada. The European Union has
also approved ActiPatch as a Class II pulsed electromagnetic medical device
as have numerous other international regulatory agencies. Information on
ActiPatch and BioElectronics Corp. is available at the following websites:



-- U.S. Consumer http://www.actipatchonline.com
-- Podiatry: www.pemfpodiatry.com
-- Plastic Surgery: www.plasticsurgery.com and www.makemeheal.com
-- German orthopedic foot & ankle: www.diesfussexperten.de
-- Italy and Switzerland: www.actipatch.it
-- BioElectronics Corp: http://www.bioelectronicscorp.com